Replies to post #2608 on Repros Therapeutics Inc (RPRX)

[DewDiligence]

>With all due respect Dew, that sounds kinda like a Jonathan Aschoff report on DNDN.<

Aschoff’s predictions on DNDN have turned out to be more accurate than the predictions of 95% of message-board posters, so I’ll take your remark as a compliment.